| Literature DB >> 35865593 |
Nguyen Quang Hop1, Ninh The Son2,3.
Abstract
Kopsia belongs to the family Apocynaceae, which was originally classified as a genus in 1823. Kopsia consists of medicinal plants that can be traditionally used to treat rheumatoid arthritis, pharyngitis, tonsillitis, and dropsy. More than one hundred and twenty-five publications have been documented relating to the phytochemical and pharmacological results, but a systematic review is not available. The goal of this study is to compile almost all of the secondary metabolites from the plants of genus Kopsia, as well as the coverage of their pharmacological research. The document findings were conducted via reliable sources, including Web of Science, Sci-Finder, Science Direct, PubMed, Google Scholar, and publishers, while four words "Kopsia", "monoterpene alkaloids", "Phytochemistry" and "Pharmacology" are key factors to search for references. Most Kopsia secondary metabolites were collected. A total of four hundred and seventy-two, including four hundred and sixty-six monoterpene alkaloids, five triterpenoids, and one sterol, were summarized, along with their resource. Kopsia monoterpene alkaloids presented in various skeletons, but aspidofractinines, eburnamines, and chanofruticosinates are the three major backbones. Mersinines and pauciflorines are new chemical classes of monoterpene alkaloids. With the rich content of monoterpene alkaloids, Kopsia constituents were also the main objects in pharmacological studies since the plant extracts and isolated compounds were proposed for anti-microbial, anti-inflammatory, anti-allergic, anti-diabetic, anti-manic, anti-nociceptive, acetylcholinesterase (AChE) inhibitory, cardiovascular, and vasorelaxant activities, especially cytotoxicity. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35865593 PMCID: PMC9253876 DOI: 10.1039/d2ra01791a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Monoterpene alkaloids and non-alkaloidal constituents from the genus Kopsia
| No. | Compounds | Species | References |
|---|---|---|---|
|
| |||
| 1 | Arbolodinine A |
|
|
| 2 | Aspidofractinine |
|
|
| 3 | (2β,5β)-Aspidofractinin-16-ol |
|
|
| 4 | Aspidofractinine-1,3-dicarboxylic acid |
|
|
| 5 |
|
|
|
| 6 |
|
|
|
| 7 |
|
|
|
| 8 |
|
|
|
| 9 |
|
|
|
| 10 | Dasyrachine |
|
|
| 11 | Decarbomethoxykopsine (demethoxycarbonylkopsin) |
|
|
| 12 | Decarbomethoxyisokopsine |
|
|
| 13 | Decarbomethoxykopsifine |
|
|
| 14 |
|
|
|
| 15 |
|
|
|
| 16 | 10-Demethoxykopsidasinine |
|
|
| 17 | 5,22-Dioxokopsane |
|
|
| 18 | 11,12-Dimethoxykopsamine |
|
|
| 19 | 11,12-Dimethoxykopsinaline |
|
|
| 20 | 16- |
|
|
| 21 | 16- |
|
|
| 22 | 16- |
|
|
| 23 | 14,15-β-Epoxykopsingine |
|
|
| 24 |
|
|
|
| 25 |
|
|
|
| 26 | Fruticosamine |
|
|
| 27 | Fruticosiamine A |
|
|
| 28 | Fruticosine |
|
|
| 29 | 11-Hydroxykopsilongine |
|
|
| 30 | 11-Hydroxykopsingine |
|
|
| 31 | 5β-Hydroxykopsinine |
|
|
| 32 | 15-Hydroxykopsamine |
|
|
| 33 | 15α-Hydroxykopsinine |
|
|
| 34 | 17α-Hydroxykopsinine |
|
|
| 35 | 17α-Hydroxy-Δ14,15-kopsinine |
|
|
| 36 | Jasminiflorine |
|
|
| 37 | Kopsamidine A |
|
|
| 38 | Kopsamidine B |
|
|
| 39 | Kopsamine |
|
|
| 40 | Kopsamine |
|
|
| 41 | Kopsanone |
|
|
| 42 | Kopsaporine |
|
|
| 43 | Kopsiafrutine A |
|
|
| 44 | Kopsiafrutine B |
|
|
| 45 | Kopsiafrutine C |
|
|
| 46 | Kopsiafrutine D |
|
|
| 47 | Kopsiafrutine E |
|
|
| 48 | Kopsiahainanin A |
|
|
| 49 | Kopsiahainanin B |
|
|
| 50 | Kopsiahainanin C |
|
|
| 51 | Kopsiahainanin D |
|
|
| 52 | Kopsiahainanin E |
|
|
| 53 | Kopsiahainanin F |
|
|
| 54 | Kopsiahainin A |
|
|
| 55 | Kopsiahainin B |
|
|
| 56 | Kopsiahainin C |
|
|
| 57 | Kopsiahainin D |
|
|
| 58 | Kopsiahainin E |
|
|
| 59 | Kopsiaofficine A |
|
|
| 60 | Kopsiaofficine B |
|
|
| 61 | Kopsiaofficine C |
|
|
| 62 | Kopsiarborines A |
|
|
| 63 | Kopsidarine |
|
|
| 64 | Kopsidasine |
|
|
| 65 | Kopsidasine- |
|
|
| 66 | Kopsidasinine |
|
|
| 67 | Kopsidine A |
|
|
| 68 | Kopsidine B |
|
|
| 69 | Kopsidine C |
|
|
| 70 | Kopsidine C |
|
|
| 71 | Kopsidine D |
|
|
| 72 | Kopsidine E |
|
|
| 73 | Kopsifine |
|
|
| 74 | Kopsiflorine |
|
|
| 75 | Kopsiflorine |
|
|
| 76 | Kopsifoline A |
|
|
| 77 | Kopsifoline B |
|
|
| 78 | Kopsifoline C |
|
|
| 79 | Kopsifoline D |
|
|
| 80 | Kopsifoline E |
|
|
| 81 | Kopsifoline F |
|
|
| 82 | Kopsifoline G |
|
|
| 83 | Kopsihainin B |
|
|
| 84 | Kopsihainin C |
|
|
| 85 | Kopsihainin D |
|
|
| 86 | Kopsihainin E |
|
|
| 87 | Kopsihainin F |
|
|
| 88 | Kopsijasminine |
|
|
| 89 | Kopsijasmine |
|
|
| 90 | Kopsilarutensinine |
|
|
| 91 | Kopsilongine |
|
|
|
| |||
| 92 | Kopsilongine- |
|
|
| 93 | Kopsiloscine A |
|
|
| 94 | Kopsiloscine B |
|
|
| 95 | Kopsiloscine C |
|
|
| 96 | Kopsiloscine D |
|
|
| 97 | Kopsiloscine E |
|
|
| 98 | Kopsiloscine F |
|
|
| 99 | Kopsiloscine G |
|
|
| 100 | Kopsiloscine H |
|
|
| 101 | Kopsiloscine I |
|
|
| 102 | Kopsiloscine J |
|
|
| 103 | Kopsimaline A |
|
|
| 104 | Kopsimaline B |
|
|
| 105 | Kopsimaline C |
|
|
| 106 | Kopsimaline D |
|
|
| 107 | Kopsimaline E |
|
|
| 108 | Kopsimaline F |
|
|
| 109 | Kopsinarine |
|
|
| 110 | Kopsine |
|
|
| 111 | Kopsinganol |
|
|
| 112 | Kopsingine |
|
|
| 113 | Kopsinginine |
|
|
| 114 | Kopsinginol |
|
|
| 115 | Kopsinidine A |
|
|
| 116 | Kopsinidine B |
|
|
| 117 | Kopsininic acid (kopsinic acid) |
|
|
| 118 | Kopsinicine |
|
|
| 119 | Kopsinidine A |
|
|
| 120 | Kopsinidine B |
|
|
| 121 | Kopsinidine C |
|
|
| 122 | Kopsinidine D |
|
|
| 123 | Kopsinidine E |
|
|
| 124 | Kopsinilam |
|
|
| 125 | Kopisininate |
|
|
| 126 | Kopsinine |
|
|
| 127 | Kopsinine- |
|
|
| 128 | Kopsinine methochloride |
|
|
| 129 | Kopsinine B |
|
|
| 130 | Kopsinine F |
|
|
| 131 | Kopsinitarine A |
|
|
| 132 | Kopsinitarine B |
|
|
| 133 | Kopsinitarine C |
|
|
| 134 | Kopsinitarine D |
|
|
| 135 | Kopsinitarine E |
|
|
| 136 | Kopsinol |
|
|
| 137 | (−)-Kopsinoline |
|
|
| 138 | Kopsiofficine A |
|
|
| 139 | Kopsiofficine B |
|
|
| 140 | Kopsiofficine C |
|
|
| 141 | Kopsiofficine D |
|
|
| 142 | Kopsiofficine E |
|
|
| 143 | Kopsiofficine F |
|
|
| 144 | Kopsiofficine L |
|
|
| 145 | Kopsofinone |
|
|
| 146 | Kopsonoline |
|
|
| 147 | Kopsorinine |
|
|
| 148 | Lahadinine A |
|
|
| 149 | Lahadinine B |
|
|
| 150 | Mersingine A |
|
|
| 151 | Mersingine B |
|
|
| 152 |
|
|
|
| 153 |
|
|
|
| 154 |
|
|
|
| 155 |
|
|
|
| 156 |
|
|
|
| 157 |
|
|
|
| 158 |
|
|
|
| 159 |
|
|
|
| 160 | 11-Methoxykopsingine |
|
|
| 161 | 11-Methoxykopsilongine |
|
|
| 162 | 11-Methoxykopsilongine |
|
|
| 163 | 11-Methoxy-12-hydroxy-kopsinol |
|
|
| 164 | 12-Methoxykopsidasinine |
|
|
| 165 | (−)-12-Methoxykopsinaline |
|
|
| 166 | 12-Methoxykopsine |
|
|
| 167 | 12-Methoxy-10-demethoxykopsidasinine |
|
|
| 168 | 12-Methoxypleiocarpine |
|
|
| 169 | (−)-Methylenedioxy-11,12-kopsinaline |
|
|
| 170 |
|
|
|
| 171 | 11,12-Methylenedioxykopsaporine |
|
|
| 172 | (−)-11,12-Methylenedioxykopsinaline |
|
|
| 173 | 11,12-Methylenedioxykopsinaline |
|
|
| 174 | 11,12-Methylenedioxykopsine |
|
|
| 175 | Nitaphylline |
|
|
| 176 | 5-Oxokopsinic acid |
|
|
| 177 | Paucidactine A |
|
|
| 178 | Paucidactine B |
|
|
| 179 | Paucidactine C |
|
|
| 180 | Paucidactine D |
|
|
| 181 | Paucidactine E |
|
|
| 182 | Paucidactinine |
|
|
| 183 | Paucidisine |
|
|
| 184 | Paucidirinine |
|
|
| 185 | Paucidirisine |
|
|
| 186 | Pauciduridine |
|
|
| 187 | Paucifinine |
|
|
| 188 | Paucifinine- |
|
|
| 189 | Pleiocarpine |
|
|
| 190 | Pleiocarpine |
|
|
| 191 | Pseudokopsinine |
|
|
| 192 | 5,6-Secokopsinine |
|
|
| 193 | Singaporentine A |
|
|
| 194 | Singapurensine A |
|
|
| 195 | Singapurensine B |
|
|
| 196 | Singapurensine C |
|
|
| 197 | Singapurensine D |
|
|
| 198 | Venacarpine A |
|
|
| 199 | Venacarpine B |
|
|
| 200 | Venalstonidine |
|
|
| 201 | (−)-Venalstonine |
|
|
| 202 | Yunnanoffine A |
|
|
| 203 | Yunnanoffine B |
|
|
| 204 | Yunnanoffine D |
|
|
|
| |||
| 205 | Chanofruticosinic acid |
|
|
| 206 |
|
|
|
| 207 | 11,12-Dimethoxydanuphylline |
|
|
| 208 | Flavisiamine A (prunifoline D) |
|
|
| 209 | Flavisiamine B |
|
|
| 210 | Flavisiamine C |
|
|
| 211 | Flavisiamine D (prunifoline E) |
|
|
| 212 | Flavisiamine E |
|
|
| 213 | Flavisiamine F |
|
|
| 214 | 12-Hydroxylprunifoline A |
|
|
| 215 | 12-Hydroxylprunifoline C |
|
|
| 216 | Kopreasin A |
|
|
| 217 | Kopsia A (methyl chanofruticosinate) |
|
|
| 218 | Kopsia B (des- |
|
|
| 219 | Kopsia C (6,7-methylendioxychanofruticosin-methylester or methyl 11,12-methylenedioxychanofruticosinate) |
|
|
| 220 | Kopsihainanine A |
|
|
| 221 | Kopsihainanine B |
|
|
| 222 | 12-Methoxychanofruticosinic acid |
|
|
| 223 | Methyl chanofruticosinate |
|
|
| 224 | Methyl 11,12-dimethoxychanofruticosinate |
|
|
| 225 | Methyl |
|
|
| 226 | Methyl |
|
|
| 227 | Methyl 12-methoxy- |
|
|
| 228 | Methyl 12-methoxychanofruticosinate |
|
|
| 229 | Methyl 11,12-methylenedioxy- |
|
|
| 230 | Methyl 11,12-methylenedioxy- |
|
|
| 231 | Methyl (2β,11β,12β,19α)-6,7-didehydro-8,21-dioxo-11,21-cycloaspidospermidine-2-carboxylate |
|
|
| 232 | Methyl 3-oxo-12-methoxy- |
|
|
| 233 | Methyl 3-oxo-11,12-methylenedioxy- |
|
|
| 234 | Δ1,2-Methyldemethoxycarbonylchanofruticosinate |
|
|
| 235 | 11,12-Methylenedioxychanofruticosinic acid |
|
|
| 236 | 3-Oxo-11,12-dimethoxy- |
|
|
| 237 |
|
|
|
| 238 | Prunifoline A |
|
|
| 239 | Prunifoline B |
|
|
| 240 | Prunifoline C |
|
|
| 241 | Prunifoline F |
|
|
|
| |||
| 242 | Aspidospermine |
|
|
| 243 | (+)-1,2-Dehydroaspidospermine |
|
|
| 244 | Eburenine |
|
|
| 245 | Kopsiofficine G |
|
|
| 246 | Kopsiyunnanine G |
|
|
| 247 | Vincadifformine |
|
|
| 248 | Vincadifformine |
|
|
|
| |||
| 249 | Danuphylline |
|
|
| 250 | Danuphylline B |
|
|
| 251 | 11,12-De(methylenedioxy)danuphylline |
|
|
| 252 | Kopsihainin A |
|
|
|
| |||
| 253 | (−)-Demethylnorpleiomutine |
|
|
| 254 | (+)-Eburnamenine |
|
|
| 255 | (−)-Eburnamenine |
|
|
| 256 | (+)-Eburnamine |
|
|
| 257 | (−)-Eburnamine |
|
|
| 258 | (−)-Eburnaminol |
|
|
| 259 | (+)-Eburnamonine |
|
|
| 260 | (+)-Eburnamonine |
|
|
| 261 | (−)-Eburnamonine |
|
|
| 262 | (−)- |
|
|
| 263 | (+)-Ethylisoeburnamine |
|
|
| 264 | 16α-Hydroxy-19-oxoeburnamine |
|
|
| 265 | 16β-Hydroxy-19-oxoeburnamine |
|
|
| 266 | (+)-19( |
|
|
| 267 | 19-Hydroxy-(−)-eburnamonine |
|
|
| 268 | (−)-19( |
|
|
| 269 | (+)-(19 |
|
|
| 270 | (−)-19( |
|
|
| 271 | (−)-(19 |
|
|
| 272 | (−)-19( |
|
|
| 273 | 19( |
|
|
| 274 | (+)-Isoeburnamine |
|
|
| 275 | (−)-Isoeburnamine |
|
|
| 276 | 16-Isoeburnamine ((+)-methylisoeburnamine) |
|
|
| 277 | (+)-Kopsoffine |
|
|
| 278 | Kopsiofficine H |
|
|
| 279 | Kopsiofficine I |
|
|
| 280 | Kopsiofficine J |
|
|
| 281 | Kopsiofficine K |
|
|
| 282 | Kopsoffinol |
|
|
| 283 | (+)-Larutensine |
|
|
| 284 | Larutenine |
|
|
| 285 | Larutenine A |
|
|
| 286 | Larutenine B |
|
|
| 287 | Melohenine B |
|
|
| 288 | (−)-Methyleburnamine |
|
|
| 289 | (−)-Norpleiomutine |
|
|
| 290 | (+)- |
|
|
| 291 | (−)- |
|
|
| 292 | (+)-19-Oxoeburnamine |
|
|
| 293 | 19-Oxo-(−)-eburnamonine |
|
|
| 294 | (−)-19-Oxoisoeburnamine |
|
|
| 295 |
|
|
|
| 296 | 20-Oxo-eburnamenine |
|
|
| 297 | Phutdonginin |
|
|
| 298 | Terengganensine A |
|
|
| 299 | Terengganensine B |
|
|
| 300 | Δ14-Vicamone |
|
|
| 301 | Yunnanoffine C |
|
|
|
| |||
| 302 | Akuammidine |
|
|
| 303 | Akuammiline |
|
|
| 304 | Akuammiline |
|
|
| 305 | ψ-Akuammigine |
|
|
| 306 | Deacetylakuammiline (rhazimol) |
|
|
| 307 | Dregamine |
|
|
| 308 | 16- |
|
|
| 309 | 16- |
|
|
| 310 | 16- |
|
|
| 311 | 16-Hydroxymethyl-pleiocarpamine |
|
|
| 312 |
|
|
|
| 313 | 5-Methoxystrictamine |
|
|
| 314 | Rhazimal |
|
|
| 315 | Rhazinaline |
|
|
| 316 | Rhazinoline |
|
|
| 317 | Picralinal |
|
|
| 318 | Picramicine |
|
|
| 319 | Pleiocarpamine |
|
|
| 320 | Pleiocarpamine methochloride |
|
|
| 321 | Pleiomalicine |
|
|
| 322 | Singaporentinidine |
|
|
|
| |||
| 323 | 10-Hydroxy-vincadiffine |
|
|
| 324 | Perivine |
|
|
| 325 | Tabernaemontanine |
|
|
| 326 | Vincadiffine |
|
|
|
| |||
| 327 | Aspidodasycarpine |
|
|
| 328 | Aspidophylline A |
|
|
| 329 | Aspidophylline B |
|
|
| 330 | Lonicerine |
|
|
| 331 | Vincophylline |
|
|
|
| |||
| 332 | Akuammicine |
|
|
| 333 | Arbolodinine B |
|
|
| 334 | Arbolodinine C |
|
|
| 335 | ( |
|
|
| 336 | ( |
|
|
| 337 | 14α-Hydroxycondylocarpine |
|
|
| 338 | 14α-Hydroxy- |
|
|
| 339 | 14( |
|
|
| 340 | Isocondylocarpine |
|
|
| 341 | Isocondylocarpine |
|
|
| 342 | Kopsiyunnanine A |
|
|
| 343 | Kopsiyunnanine I |
|
|
| 344 | Kopsiyunnanine J1 |
|
|
| 345 | Kopsiyunnanine J2 |
|
|
| 346 | Kopsiyunnanine L |
|
|
| 347 | Kopsiyunnanine M |
|
|
| 348 | Kopsiyunnanine F1 |
|
|
| 349 | Kopsiyunnanine F2 |
|
|
| 350 | Kopsiyunnanine F3 |
|
|
| 351 | Leuconicine B |
|
|
| 352 | 19( |
|
|
| 353 | 19( |
|
|
| 354 | Mossambine |
|
|
| 355 | Precondylocarpine |
|
|
| 356 | Tubotaiwine |
|
|
|
| |||
| 357 | Stemmadenine |
|
|
|
| |||
| 358 | Mersidasine A |
|
|
| 359 | Mersidasine B |
|
|
| 360 | Mersidasine C |
|
|
| 361 | Mersidasine D |
|
|
| 362 | Mersidasine E |
|
|
| 363 | Mersidasine F |
|
|
| 364 | Mersidasine G |
|
|
| 365 | Mersifoline A |
|
|
| 366 | Mersifoline B |
|
|
| 367 | Mersifoline C |
|
|
| 368 | Mersilongine |
|
|
| 369 | Mersiloscine |
|
|
| 370 | Mersiloscine A |
|
|
| 371 | Mersiloscine B |
|
|
| 372 | Mersinaline |
|
|
| 373 | Mersinine A |
|
|
| 374 | Mersinine B |
|
|
| 375 | Mersinine C |
|
|
| 376 | Mersiphyllines A |
|
|
| 377 | Mersiphyllines B |
|
|
| 378 | Mersirachine |
|
|
|
| |||
| 379 | 11,12-Demethoxy-16-deoxypauciflorine |
|
|
| 380 | 20-Deoxykopsijasminilam |
|
|
| 381 | Kopsiarborines C |
|
|
| 382 | Kopsijasminilam |
|
|
| 383 | Δ14-Kopsijasminilam |
|
|
| 384 | Kopsioffine A |
|
|
| 385 | Kopsioffine B |
|
|
| 386 | Kopsioffine C |
|
|
| 387 | Pauciflorine A |
|
|
| 388 | Pauciflorine B |
|
|
| 389 | Pauciflorine C |
|
|
| 390 | Paucifoline |
|
|
|
| |||
| 391 | Kinabalurine A (kinabalurine) |
|
|
| 392 | Kinabalurine B |
|
|
| 393 | Kinabalurine C |
|
|
| 394 | Kinabalurine D |
|
|
| 395 | Kinabalurine E |
|
|
| 396 | Kinabalurine F |
|
|
| 397 | Kinabalurine G |
|
|
| 398 | Kopsilactone |
|
|
| 399 | Kopsirachine |
|
|
| 400 | Kopsone |
|
|
|
| |||
| 401 | 5,21-Dihydrorhazinilam |
|
|
| 402 | Kopsiyunnanine C1 |
|
|
| 403 | Kopsiyunnanine C2 |
|
|
| 404 | Kopsiyunnanine C3 |
|
|
| 405 | Leuconolam |
|
|
| 406 |
|
|
|
| 407 | Rhazinal |
|
|
| 408 | Rhazinicine |
|
|
| 409 | Rhazinilam |
|
|
|
| |||
| 410 | Epilapidilectinol |
|
|
| 411 | Grandilodine A |
|
|
| 412 | Grandilodine B |
|
|
| 413 | Grandilodine C |
|
|
| 414 | Isolapidilectine A |
|
|
| 415 | Lapidilectam |
|
|
| 416 | Lapidilectine A |
|
|
| 417 | Lapidilectine B |
|
|
| 418 | Lapidilectinol |
|
|
| 419 | Lundurine A |
|
|
| 420 | Lundurine B |
|
|
| 421 | Lundurine C |
|
|
| 422 | Lundurine D |
|
|
| 423 | Tenuisine A |
|
|
| 424 | Tenuisine B |
|
|
| 425 | Tenuisine C |
|
|
| 426 | Tenuiphylline |
|
|
|
| |||
| 427 | Buchtienine |
|
|
| 428 | Corynantheol |
|
|
| 429 | 19,20-Dihydroisositsirikine |
|
|
| 430 | Dihydrocorynantheol |
|
|
| 431 | 16( |
|
|
|
| |||
| 432 | Catharinensine |
|
|
| 433 | Kopsirensine A |
|
|
| 434 | Kopsirensine B |
|
|
| 435 | Kopsirensine C |
|
|
| 436 | Kopsiyunnanine B |
|
|
|
| |||
| 437 | Arboloscine |
|
|
| 438 | Arboloscine A |
|
|
| 439 | Leuconodine D |
|
|
| 440 | Leuconodine F (6-oxoleuconoxine) |
|
|
| 441 | Leuconoxine |
|
|
| 442 | Melodinine E |
|
|
|
| |||
| 443 | Pericidine |
|
|
| 444 | Pericine |
|
|
| 445 | Pericine |
|
|
| 446 | Valparicine |
|
|
|
| |||
| 447 | Oxayohimban-16-carboxy acid |
|
|
| 448 | (−)-Tetrahydroalstonine |
|
|
| 449 | Tetrahydroalstonine pseudoindoxyl |
|
|
|
| |||
| 450 | Kopsiyunnanine D |
|
|
| 451 | Kopsiyunnanine H |
|
|
| 452 | (−)-Quebrachamine |
|
|
|
| |||
| 453 | Arbophyllinine A |
|
|
| 454 | Arbophyllinine B |
|
|
|
| |||
| 455 | Arboflorine |
|
|
| 456 | Kopsiyunnanine E |
|
|
|
| |||
| 457 | Andransinine |
|
|
| 458 | Andransinine A |
|
|
|
| |||
| 459 | Arboricine |
|
|
| 460 | Arboricinine |
|
|
|
| |||
| 461 | Harmane |
|
|
| 462 | Harmicine |
|
|
|
| |||
| 463 | Arbophyllidine |
|
|
|
| |||
| 464 | Mersicarpine |
|
|
|
| |||
| 465 | Kopsiyunnanine K |
|
|
|
| |||
| 466 | Andranginine |
|
|
|
| |||
| 467 | β-Amyrin |
|
|
| 468 | β-Amyrin acetate |
|
|
| 469 | β-Amyrone |
|
|
| 470 | Lupeol |
|
|
| 471 | Lupeol acetate |
|
|
| 472 | Stigmasterol |
|
|
Fig. 1Aspidofractinines from genus Kopsia.
Fig. 2Chanofruticosinates, aspidospermines and danuphyllines from genus Kopsia.
Fig. 3Eburnamines from genus Kopsia.
Fig. 4Akuammilines, sarpagines and aspidophyllines from genus Kopsia.
Fig. 5Strychnoses and stemmadenine from genus Kopsia.
Fig. 6Mersinines and pauciflorines from genus Kopsia.
Fig. 7Skytanthines, rhazinilams and lundurines from genus Kopsia.
Fig. 8Aspidospermas, catharinensines, leuconoxines, pericines, alstonines and quebrachamines from genus Kopsia.
Fig. 9Others type indole alkaloids from genus Kopsia.
Fig. 10Triterpenoids and sterol from genus Kopsia.
Pharmacological activities of isolated compounds and plant extracts from the genus Kopsia
| Compounds | Models | Effect | Positive control | Effect | References |
|---|---|---|---|---|---|
|
| |||||
| 39 |
| CD50 > 60 μg mL−1/NIH/3T3 and HeLa cells | Vincristine | CD50 > 60 μg mL−1/NIH/3T3 cells |
|
| CD50 = 6.9 μg mL−1/HL-60 cells | CD50 = 1.8 μg mL−1/HL-60 cells | ||||
| CD50 = 0.4 μg mL−1/HeLa cells | |||||
| 40 |
| CD50 > 60 μg mL−1/NIH/3T3, HL-60 and HeLa cells | Vincristine | CD50 > 60 μg mL−1/NIH/3T3 cells |
|
| CD50 = 1.8 μg mL−1/HL-60 cells | |||||
| CD50 = 0.4 μg mL−1/HeLa cells | |||||
| 43 |
| IC50 = 33.7 μM/HS-1 cells | Adiamycin | IC50 = 17.8 μM/HS-1 cells |
|
| IC50 = 28.4 μM/HS-4 cells | IC50 = 24.7 μM/HS-4 cells | ||||
| IC50 = 32.4 μM/SCL-1 cells | IC50 = 21.8 μM/SCL-1 cells | ||||
| IC50 = 29.7 μM/A-431 cells | IC50 = 33.7 μM/A-431 cells | ||||
| IC50 = 30.9 μM/BGC-823 cells | IC50 = 28.4 μM/BGC-823 cells | ||||
| IC50 = 27.1 μM/MCF-7 cells | IC50 = 37.6 μM/MCF-7 cells | ||||
| IC50 = 31.2 μM/W-480 cells | IC50 = 14.1 μM/W-480 cells | ||||
| 44 |
| IC50 = 34.9 μM/HS-1 cells | Adiamycin | IC50 = 17.8 μM/HS-1 cells |
|
| IC50 = 29.9 μM/HS-4 cells | IC50 = 24.7 μM/HS-4 cells | ||||
| IC50 = 33.1 μM/SCL-1 cells | IC50 = 21.8 μM/SCL-1 cells | ||||
| IC50 = 30.1 μM/A-431 cells | IC50 = 33.7 μM/A-431 cells | ||||
| IC50 = 35.5 μM/BGC-823 cells | IC50 = 28.4 μM/BGC-823 cells | ||||
| IC50 = 31.2 μM/MCF-7 cells | IC50 = 37.6 μM/MCF-7 cells | ||||
| IC50 = 32.6 μM/W-480 cells | IC50 = 14.1 μM/W-480 cells | ||||
| 45 |
| IC50 = 12.4 μM/HS-1 cells | Adiamycin | IC50 = 17.8 μM/HS-1 cells |
|
| IC50 = 12.3 μM/HS-4 and BGC-823 cells | IC50 = 24.7 μM/HS-4 cells | ||||
| IC50 = 12.9 μM/SCL-1 cells | IC50 = 21.8 μM/SCL-1 cells | ||||
| IC50 = 11.8 μM/A-431 cells | IC50 = 33.7 μM/A-431 cells | ||||
| IC50 = 12.6 μM/MCF-7 cells | IC50 = 28.4 μM/BGC-823 cells | ||||
| IC50 = 13.8 μM/W-480 cells | IC50 = 37.6 μM/MCF-7 cells | ||||
| IC50 = 14.1 μM/W-480 cells | |||||
| 46 |
| IC50 = 11.6 μM/HS-1 cells | Adiamycin | IC50 = 17.8 μM/HS-1 cells |
|
| IC50 = 11.4 μM/HS-4 cells | IC50 = 24.7 μM/HS-4 cells | ||||
| IC50 = 12.1 μM/SCL-1 cells | IC50 = 21.8 μM/SCL-1 cells | ||||
| IC50 = 10.3 μM/A-431 cells | IC50 = 33.7 μM/A-431 cells | ||||
| IC50 = 11.7 μM/BGC-823 cells | IC50 = 28.4 μM/BGC-823 cells | ||||
| IC50 = 10.4 μM/MCF7 cells | IC50 = 37.6 μM/MCF-7 cells | ||||
| IC50 = 12.5 μM/W-480 cells | IC50 = 14.1 μM/W-480 cells | ||||
| 47 |
| IC50 = 7.3 μM/HS-1 cells | Adiamycin | IC50 = 17.8 μM/HS-1 cells |
|
| IC50 = 8.6 μM/HS-4 and MCF-7 cells | IC50 = 24.7 μM/HS-4 cells | ||||
| IC50 = 8.2 μM/SCL-1 cells | IC50 = 21.8 μM/SCL-1 cells | ||||
| IC50 = 9.5 μM/A431 cells | IC50 = 33.7 μM/A-431 cells | ||||
| IC50 = 8.9 μM/BGC-823 cells | IC50 = 28.4 μM/BGC-823 cells | ||||
| IC50 = 9.2 μM/W-480 cells | IC50 = 37.6 μM/MCF-7 cells | ||||
| IC50 = 14.1 μM/W-480 cells | |||||
| 48 |
| IC50 = 11.3 μM/A-549 cells | Doxorubicin | IC50 = 0.02 μM/A-549, HepG-2 and W-480 cells |
|
| IC50 = 9.4 μM/BGC-823 cells | IC50 = 0.01 μM/BGC-823 cells | ||||
| IC50 = 10.1 μM/HepG-2 cells | IC50 = 0.03 μM/HL-60 cells | ||||
| IC50 = 11.1 μM/HL-60 cells | IC50 = 0.04 μM/SMMC-7721 cells | ||||
| IC50 = 10.4 μM/MCF-7 cells | |||||
| IC50 = 9.7 μM/SMMC-7721 cells | |||||
| IC50 = 11.7 μM/W-480 cells | |||||
| 49 |
| IC50 = 12.7 μM/A-549 cells | Doxorubicin | IC50 = 0.02 μM/A-549, HepG-2 and W-480 cells |
|
| IC50 = 12.2 μM/BGC-823 cells | IC50 = 0.01 μM/BGC-823 cells | ||||
| IC50 = 12.8 μM/HepG-2 cells | IC50 = 0.03 μM/HL-60 cells | ||||
| IC50 = 13.8 μM/HL-60 cells | IC50 = 0.04 μM/SMMC-7721 cells | ||||
| IC50 = 14.3 μM/MCF-7 and SMMC-7721 cells | |||||
| IC50 = 15.9 μM/W-480 cells | |||||
| 50 |
| IC50 = 31.9 μM/A-549 cells | Doxorubicin | IC50 = 0.02 μM/A-549, HepG-2 and W-480 cells |
|
| IC50 = 31.2 μM/BGC-823 cells | IC50 = 0.01 μM/BGC-823 cells | ||||
| IC50 = 30.7 μM/HepG-2 cells | IC50 = 0.03 μM/HL-60 cells | ||||
| IC50 = 32.2 μM/HL-60 cells | IC50 = 0.04 μM/SMMC-7721 cells | ||||
| IC50 = 28.1 μM/MCF-7 cells | |||||
| IC50 = 29.9 μM/SMMC-7721 cells | |||||
| IC50 = 27.6 μM/W-480 cells | |||||
| 51 |
| IC50 = 29.7 μM/A-549 cells | Doxorubicin | IC50 = 0.02 μM/A-549, HepG-2 and W-480 cells |
|
| IC50 = 29.6 μM/BGC-823 cells | IC50 = 0.01 μM/BGC-823 cells | ||||
| IC50 = 29.4 μM/HepG-2 and HL-60 cells | IC50 = 0.03 μM/HL-60 cells | ||||
| IC50 = 27.1 μM/MCF-7 cells | IC50 = 0.04 μM/SMMC-7721 cells | ||||
| IC50 = 30.1 μM/SMMC-7721 cells | |||||
| IC50 = 24.9 μM/W-480 cells | |||||
| 52 |
| IC50 = 76.3 μM/A-549 cells | Doxorubicin | IC50 = 0.02 μM/A-549, HepG-2 and W-480 cells |
|
| IC50 = 68.7 μM/BGC-823 cells | IC50 = 0.01 μM/BGC-823 cells | ||||
| IC50 = 66.8 μM/HepG-2 cells | IC50 = 0.03 μM/HL-60 cells | ||||
| IC50 = 72.3 μM/HL-60 cells | IC50 = 0.04 μM/SMMC-7721 cells | ||||
| IC50 = 76.2 μM/MCF-7 cells | |||||
| IC50 = 70.8 μM/SMMC-7721 cells | |||||
| IC50 = 69.4 μM/W-480 cells | |||||
| 53 |
| IC50 = 80.2 μM/A-549 cells | Doxorubicin | IC50 = 0.02 μM/A-549, HepG-2 and W-480 cells |
|
| IC50 = 78.8 μM/BGC-823 cells | IC50 = 0.01 μM/BGC-823 cells | ||||
| IC50 = 79.4 μM/HepG-2 cells | IC50 = 0.03 μM/HL-60 cells | ||||
| IC50 = 80.3 μM/HL-60 cells | IC50 = 0.04 μM/SMMC-7721 cells | ||||
| IC50 = 80.5 μM/MCF-7 cells | |||||
| IC50 = 81.6 μM/SMMC-7721 cells | |||||
| IC50 = 81.8 μM/W-480 cells | |||||
| 54 |
| IC50 = 15.8 μM/BGC-823 cells | Doxorubicin | IC50 = 0.02 μM/BGC-823 cells |
|
| IC50 = 16.8 μM/HepG-2 cells | IC50 = 0.01 μM/HepG-2 and SK-OV-3 cells | ||||
| IC50 = 16.5 μM/MCF-7 cells | IC50 = 0.06 μM/MCF-7 cells | ||||
| IC50 = 18.7 μM/SGC-7901 cells | IC50 = 0.05 μM/SGC-7901 cells | ||||
| IC50 = 19.7 μM/SK-MEL-2 cells | IC50 = 0.03 μM/SK-MEL-2 cells | ||||
| IC50 = 17.6 μM/SK-OV-3 cells | |||||
| 55 |
| IC50 = 13.8 μM/BGC-823 cells | Doxorubicin | IC50 = 0.02 μM/BGC-823 cells |
|
| IC50 = 12.4 μM/HepG-2 cells | IC50 = 0.01 μM/HepG-2 and SK-OV-3 cells | ||||
| IC50 = 14.8 μM/MCF-7 cells | IC50 = 0.06 μM/MCF-7 cells | ||||
| IC50 = 13.9 μM/SGC-7901 and SK-OV-3 cells | IC50 = 0.05 μM/SGC-7901 cells | ||||
| IC50 = 12.6 μM/SK-MEL-2 cells | IC50 = 0.03 μM/SK-MEL-2 cells | ||||
| 56 |
| IC50 = 7.3 μM/BGC-823 cells | Doxorubicin | IC50 = 0.02 μM/BGC-823 cells |
|
| IC50 = 8.6 μM/HepG-2 cells | IC50 = 0.01 μM/HepG-2 and SK-OV-3 cells | ||||
| IC50 = 8.2 μM/MCF-7 cells | IC50 = 0.06 μM/MCF-7 cells | ||||
| IC50 = 9.5 μM/SGC-7901 cells | IC50 = 0.05 μM/SGC-7901 cells | ||||
| IC50 = 8.9 μM/SK-MEL-2 cells | IC50 = 0.03 μM/SK-MEL-2 cells | ||||
| IC50 = 8.6 μM/SK-OV-3 cells | |||||
| 57 |
| IC50 = 9.5 μM/BGC-823 cells | Doxorubicin | IC50 = 0.02 μM/BGC-823 cells |
|
| IC50 = 10.6 μM/HepG-2 cells | IC50 = 0.01 μM/HepG-2 and SK-OV-3 cells | ||||
| IC50 = 9.3 μM/MCF-7 cells | IC50 = 0.06 μM/MCF-7 cells | ||||
| IC50 = 10.4 μM/SGC-7901 cells | IC50 = 0.05 μM/SGC-7901 cells | ||||
| IC50 = 9.2 μM/SK-MEL-2 cells | IC50 = 0.03 μM/SK-MEL-2 cells | ||||
| IC50 = 10.3 μM/SK-OV-3 cells | |||||
| 58 |
| IC50 = 33.1 μM/BGC-823 cells | Doxorubicin | IC50 = 0.02 μM/BGC-823 cells |
|
| IC50 = 32.4 μM/HepG-2 cells | IC50 = 0.01 μM/HepG-2 and SK-OV-3 cells | ||||
| IC50 = 29.7 μM/MCF-7 cells | IC50 = 0.06 μM/MCF-7 cells | ||||
| IC50 = 30.9 μM/SGC-7901 cells | IC50 = 0.05 μM/SGC-7901 cells | ||||
| IC50 = 27.1 μM/SK-MEL-2 cells | IC50 = 0.03 μM/SK-MEL-2 cells | ||||
| IC50 = 30.1 μM/SK-OV-3 cells | |||||
| 59 |
| IC50 = 12.9 μM/95-D cells | Doxorubicin | IC50 = 24.7 μM/95-D cells |
|
| IC50 = 12.4 μM/A-549 cells | IC50 = 21.8 μM/A-549 cells | ||||
| IC50 = 13.8 μM/ATCC cells | IC50 = 33.7 μM/ATCC cells | ||||
| IC50 = 14.8 μM/H-446 cells | IC50 = 22.3 μM/H-446 cells | ||||
| IC50 = 13.3 μM/H-460 cells | IC50 = 14.1 μM/H-460 cells | ||||
| IC50 = 12.6 μM/H-292 cells | IC50 = 13.7 μM/H-292 cells | ||||
| IC50 = 13.9 μM/SPCA-1 cells | IC50 = 14.1 μM/SPCA-1 cells | ||||
| 60 |
| IC50 = 46.8 μM/95-D cells | Doxorubicin | IC50 = 24.7 μM/95-D cells |
|
| IC50 = 47.1 μM/ATCC cells | IC50 = 33.7 μM/ATCC cells | ||||
| IC50 = 46.6 μM/H-446 cells | IC50 = 22.3 μM/H-446 cells | ||||
| IC50 = 45.9 μM/H-292 cells | IC50 = 13.7 μM/H-292 cells | ||||
| 61 |
| IC50 = 9.5 μM/95-D cells | Doxorubicin | IC50 = 24.7 μM/95-D cells |
|
| IC50 = 8.6 μM/A-549 cells | IC50 = 21.8 μM/A-549 cells | ||||
| IC50 = 9.3 μM/ATCC and H-292 cells | IC50 = 33.7 μM/ATCC cells | ||||
| IC50 = 9.4 μM/H-446 cells | IC50 = 22.3 μM/H-446 cells | ||||
| IC50 = 9.2 μM/H-460 cells | IC50 = 14.1 μM/H-460 cells | ||||
| IC50 = 9.7 μM/SPCA-1 cells | IC50 = 13.7 μM/H-292 cells | ||||
| IC50 = 14.1 μM/SPCA-1 cells | |||||
| 73 |
| CD50 = 20.7 μg mL−1/NIH/3T3 cells | Vincristine | CD50 > 60 μg mL−1/NIH/3T3 cells |
|
| CD50 = 0.9 μg mL−1/HL-60 cells | CD50 = 1.8 μg mL−1/HL-60 cells | ||||
| CD50 = 36.5 μg mL−1/HeLa cells | CD50 = 0.4 μg mL−1/HeLa cells | ||||
| 74 |
| To suppress the bound of [3H]azidopine to |
| ||
| 76 |
| IC50 = 67.3 μM/HS-4 cells | Adiamycin | IC50 = 24.7 μM/HS-4 cells |
|
| IC50 = 74.2 μM/A-431 cells | IC50 = 33.7 μM/A-431 cells | ||||
| IC50 = 66.2 μM/W-480 cells | IC50 = 14.1 μM/W-480 cells | ||||
| 88 |
| IC50 = 38.7 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 93 |
| IC50 = 19.5 μg mL−1/KB cells | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| IC50 = 18.0 μg mL−1/KB (VJ300) cells | |||||
| IC50 = 3.80 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | |||||
| 102 |
| IC50 = 15.0 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 103 |
| IC50 = 3.9 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 104 |
| IC50 = 13.0 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 105 |
| IC50 = 18.2 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 106 |
| IC50 = 9.2 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 107 |
| IC50 = 18.0 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 214 |
| IC50 = 29.7 μM/BGC-823 cells | Doxorubicin | IC50 = 29.7 μM/BGC-823 cells |
|
| IC50 = 37.6 μM/HepG-2 cells | IC50 = 37.6 μM/HepG-2 cells | ||||
| IC50 = 35.8 μM/MCF-7 cells | IC50 = 35.8 μM/MCF-7 cells | ||||
| IC50 = 36.8 μM/SGC-7901 cells | IC50 = 36.8 μM/SGC-7901 cells | ||||
| IC50 = 36.5 μM/SK-MEL-2 cells | IC50 = 36.5 μM/SK-MEL-2 cells | ||||
| 215 |
| IC50 = 32.1 μM/BGC-823 cells | Doxorubicin | IC50 = 29.7 μM/BGC-823 cells |
|
| IC50 = 29.8 μM/HepG-2 cells | IC50 = 37.6 μM/HepG-2 cells | ||||
| IC50 = 31.9 μM/MCF-7 cells | IC50 = 35.8 μM/MCF-7 cells | ||||
| IC50 = 27.9 μM/SGC-7901 cells | IC50 = 36.8 μM/SGC-7901 cells | ||||
| IC50 = 33.3 μM/SK-MEL-2 cells | IC50 = 36.5 μM/SK-MEL-2 cells | ||||
| 237 |
| IC50 = 8.6 μM/BGC-823 cells | Doxorubicin | IC50 = 29.7 μM/BGC-823 cells |
|
| IC50 = 7.2 μM/HepG-2 cells | IC50 = 37.6 μM/HepG-2 cells | ||||
| IC50 = 8.3 μM/MCF-7 cells | IC50 = 35.8 μM/MCF-7 cells | ||||
| IC50 = 8.2 μM/SGC-7901 cells | IC50 = 36.8 μM/SGC-7901 cells | ||||
| IC50 = 8.9 μM/SK-MEL-2 cells | IC50 = 36.5 μM/SK-MEL-2 cells | ||||
| 282 |
| IC50 = 9.7 μg mL−1/PC-3 cells | Cisplatin | IC50 = 1.5 μg mL−1/PC-3 cells |
|
| IC50 = 15.9 μg mL−1/HCT-116 cells | IC50 = 3.2 μg mL−1/HCT-116 cells | ||||
| IC50 = 14.1 μg mL−1/MCF-7 cells | IC50 = 4.2 μg mL−1/MCF-7 cells | ||||
| IC50 > 25 μg mL−1/A-549 and KB (VJ300) cells | IC50 = 4.3 μg mL−1/A-549 cells | ||||
| IC50 = 8.6 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Verapamil | IC50 = 4.7 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | |||
| 289 |
| IC50 = 7.1 μg mL−1/PC-3 cells | Cisplatin | IC50 = 1.5 μg mL−1/PC-3 cells |
|
| IC50 = 7.6 μg mL−1/HCT-116 cells | IC50 = 3.2 μg mL−1/HCT-116 cells | ||||
| IC50 = 9.7 μg mL−1/MCF-7 cells | IC50 = 4.2 μg mL−1/MCF-7 cells | ||||
| IC50 = 20.4 μg mL−1/A-549 cells | IC50 = 4.3 μg mL−1/A-549 cells | ||||
| IC50 = 23 μg mL−1/KB (VJ300) cells | |||||
| IC50 = 4.80 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Verapamil | IC50 = 4.7 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | |||
| 302 |
| CD50 > 60 μg mL−1/NIH/3T3 cells | Vincristine | CD50 > 60 μg mL−1/NIH/3T3 cells |
|
| CD50 = 30.2 μg mL−1/HL-60 cells | CD50 = 1.8 μg mL−1/HL-60 cells | ||||
| CD50 = 2.8 μg mL−1/HeLa cells | CD50 = 0.4 μg mL−1/HeLa cells | ||||
| 327 |
| CD50 = 6.4 μg mL−1/NIH/3T3 cells | Vincristine | CD50 > 60 μg mL−1/NIH/3T3 cells |
|
| CD50 > 60 μg mL−1/HL-60 cells | CD50 = 1.8 μg mL−1/HL-60 cells | ||||
| CD50 = 7.5 μg mL−1/HeLa cells | CD50 = 0.4 μg mL−1/HeLa cells | ||||
| 333 |
| IC50 = 1.3 μg mL−1/HT-29 cells | Cisplatin | IC50 = 8.8 μg mL−1/HT-29 cells |
|
| IC50 = 4.9 μg mL−1/MCF-7 cells | IC50 = 6.6 μg mL−1/MCF-7 cells | ||||
| IC50 = 4.7 μg mL−1/PC-3 cells | IC50 = 4.2 μg mL−1/PC-3 cells | ||||
| IC50 = 7.0 μg mL−1/MDA-MB -231 cells | IC50 = 2.1 μg mL−1/MDA-MB -231 cells | ||||
| IC50 = 7.3 μg mL−1/HCT-116 cells | IC50 = 4.6 μg mL−1/HCT-116 cells | ||||
| IC50 = 9.6 μg mL−1/A-549 cells | IC50 = 5.4 μg mL−1/A-549 cells | ||||
| IC50 = 3.0 μg mL−1/KB (VJ300) cells | Vincristine | IC50 = 0.8 μg mL−1/KB (VJ300) cells | |||
| 366 |
| IC50 = 3.70 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 367 |
| IC50 = 7.0 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 373 |
| IC50 = 4.1 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 374 |
| IC50 = 3.2 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 375 |
| IC50 = 11.2 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 402 |
| IC50 = 5.38 μM/A-549 cells | Docetaxel | IC50 = 4.95 × 10−4 μM/A-549 cells |
|
| IC50 = 4.67 μM/HT-29 cells | IC50 = 3.34 × 10−4 μM/HT-29 cells | ||||
| 403 |
| IC50 = 7.44 μM/A-549 cells | Docetaxel | IC50 = 4.95 × 10−4 μM/A-549 cells |
|
| IC50 = 6.39 μM/HT-29 cells | IC50 = 3.34 × 10−4 μM/HT-29 cells | ||||
| 404 |
| IC50 = 8.21 μM/A-549 cells | Docetaxel | IC50 = 4.95 × 10−4 μM/A-549 cells |
|
| IC50 = 8.89 μM/HT-29 cells | IC50 = 3.34 × 10−4 μM/HT-29 cells | ||||
| 407 |
| IC50 = 0.24 μg mL−1/KB cells | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| IC50 = 0.25 μg mL−1/KB (VJ300) cells | |||||
| IC50 = 0.30 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | |||||
| 408 |
| CD50 = 20.8 μg mL−1/NIH/3T3 cells | Vincristine | CD50 > 60 μg mL−1/NIH/3T3 cells |
|
| CD50 > 60 μg mL−1/HL-60 cells | CD50 = 1.8 μg mL−1/HL-60 cells | ||||
| CD50 = 2.9 μg mL−1/HeLa cells | CD50 = 0.4 μg mL−1/HeLa cells | ||||
| IC50 = 0.19 μg mL−1/KB cells | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
| ||
| IC50 = 0.25 μg mL−1/KB (VJ300) cells | |||||
| IC50 = 0.34 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | |||||
| 409 |
| IC50 = 0.35 μM/A-549 and HT-29 cells | Docetaxel | IC50 = 4.95 × 10−4 μM/A-549 cells |
|
| IC50 = 1.25 μg mL−1/KB cells | IC50 = 3.34 × 10−4 μM/HT-29 cells | ||||
| IC50 = 2.50 μg mL−1/KB (VJ300) cells | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
| ||
| IC50 = 1.85 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | |||||
| 411 |
| IC50 = 4.35 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 413 |
| IC50 = 4.11 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 417 |
| IC50 = 0.39 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 434 |
| IC50 = 21.8 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 437 |
| IC50 = 15.0 μg mL−1/KB cells | Vincadifformine | IC50 = 10.2 μg mL−1/KB cells |
|
| IC50 = 11.0 μg mL−1/KB (VJ300) cells | IC50 = 6.3 μg mL−1/KB (VJ300) cells | ||||
| IC50 = 3.8 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | IC50 = 4.5 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | ||||
| 438 |
| IC50 = 6.4 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | Vincristine | IC50 = 1.0 μg mL−1/KB (VJ300) |
|
| 446 |
| IC50 = 0.25 μg mL−1/Jurkat cells | Vincadifformine | IC50 = 21.8 μg mL−1/Jurkat cells |
|
| IC50 = 3.6 μg mL−1/KB cells | IC50 = 10.2 μg mL−1/KB cells | ||||
| IC50 = 0.75 μg mL−1/KB (VJ300) cells | IC50 = 6.3 μg mL−1/KB (VJ300) cells | ||||
| IC50 = 0.46 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | IC50 = 4.5 μg mL−1/KB (VJ300) + 0.1 μg mL−1 vincristine | ||||
| 450 and 452 |
| IC50 > 30 μM/A-549 cells | Docetaxel | IC50 = 4.95 × 10−4 μM/A-549 cells |
|
| IC50 = 30 μM/HT-29 cells | IC50 = 3.34 × 10−4 μM/HT-29 cells | ||||
| 463 |
| IC50 = 6.2 μM/HT-29 cells |
| ||
| 467 |
| IC50 = 15.5 μg mL−1/MCF-7 cells |
| ||
| 468 |
| IC50 = 22.5 μg mL−1/MCF-7 cells |
| ||
| 469 |
| IC50 = 21.5 μg mL−1/MCF-7 cells |
| ||
| 470 |
| IC50 = 17 μg mL−1/MCF-7 cells |
| ||
| 471 |
| IC50 = 26 μg mL−1/MCF-7 cells |
| ||
| 472 |
| IC50 = 14.5 μg mL−1/MCF-7 cells |
| ||
|
| |||||
| 14 |
| MIC = 31.3 μg mL−1/ | Ampicillin | MIC = 100 μg mL−1/ |
|
| MIC = 15.5 μg mL−1 | MIC = 12.5 μg mL−1/ | ||||
| MIC = 25.0 μg mL−1/ | |||||
| EC50 = 33.3 μg mL−1/ | Mildothane | EC50 = 17.0 μg mL−1/ | |||
| EC50 = 29.2 μg mL−1/ | EC50 = 7.8 μg mL−1/ | ||||
| EC50 = 16.3 μg mL−1/ | EC50 = 57.0 μg mL−1/ | ||||
| EC50 = 31.8 μg mL−1/ | EC50 = 101.0 μg mL−1/ | ||||
| 43 |
| IZ = 11 mm/ | Sanguinarine | IZ = 25 mm/ |
|
| IZ = 10 mm/ | Netilmicin | IZ = 21 mm/ | |||
| IZ = 9 mm/ | IZ = 8 mm/ | ||||
| IZ = 8 mm/ | IZ = 24 mm/ | ||||
| IZ = 7 mm/ | IZ = 22 mm/ | ||||
| IZ = 23 mm/ | |||||
| 44 |
| IZ = 12 mm/ | Sanguinarine | IZ = 25 mm/ |
|
| IZ = 11 mm/ | Netilmicin | IZ = 21 mm/ | |||
| IZ = 10 mm/ | IZ = 8 mm/ | ||||
| IZ = 9 mm/ | IZ = 24 mm/ | ||||
| IZ = 8 mm/ | IZ = 22 mm/ | ||||
| IZ = 7 mm/ | IZ = 23 mm/ | ||||
| 45 |
| IZ = 18 mm and MIC = 0.77 mM/ | Sanguinarine | IZ = 25 mm/ |
|
| IZ = 18 mm and MIC = 0.87 mM/ | Netilmicin | IZ = 21 mm/ | |||
| IZ = 17 mm and MIC = 0.89 mM/ | IZ = 8 mm/ | ||||
| IZ = 18 mm and MIC = 0.97 mM/ | IZ = 24 mm/ | ||||
| IZ = 18 mm and MIC = 0.97 mM/ | IZ = 22 mm/ | ||||
| IZ = 19 mm and MIC = 1.01 mM/ | IZ = 23 mm/ | ||||
| IZ = 18 mm and MIC = 1.13 mM/ | |||||
| IZ = 19 mm and MIC = 1.18 mM/ | |||||
| IZ = 18 mm and MIC = 2.68 mM/ | |||||
| IZ = 17 mm and MIC = 2.87 mM/ | |||||
| IZ = 17 mm and MIC = 3.09 mM/ | |||||
| 46 |
| IZ = 20 mm and MIC = 0.72 mM/ | Sanguinarine | IZ = 25 mm/ |
|
| IZ = 20 mm and MIC = 0.82 mM/ | |||||
| IZ = 20 mm and MIC = 0.91 mM/ | |||||
| IZ = 20 mm and MIC = 1.03 mM/ | |||||
| IZ = 20 mm and MIC = 1.11 mM/ | |||||
| IZ = 20 mm and MIC = 1.18 mM/ | Netilmicin | IZ = 21 mm/ | |||
| IZ = 19 mm and MIC = 1.20 mM/ | IZ = 8 mm/ | ||||
| IZ = 20 mm and MIC = 1.23 mM/ | IZ = 24 mm/ | ||||
| IZ = 17 mm and MIC = 1.32 mM/ | IZ = 22 mm/ | ||||
| IZ = 21 mm and MIC = 1.37 mM/ | IZ = 23 mm/ | ||||
| IZ = 17 mm and MIC = 2.87 mM/ | |||||
| 47 |
| IZ = 24 mm and MIC = 0.15 mM/ | Sanguinarine | IZ = 25 mm/ |
|
| IZ = 24 mm and MIC = 0.20 mM/ | |||||
| IZ = 23 mm and MIC = 0.22 mM/ | |||||
| IZ = 23 mm and MIC = 0.30 mM/ | |||||
| IZ = 24 mm and MIC = 0.30 mM/ | |||||
| IZ = 24 mm and MIC = 0.25 mM/ | Netilmicin | IZ = 21 mm/ | |||
| IZ = 24 mm and MIC = 0.27 mM/ | IZ = 8 mm/ | ||||
| IZ = 24 mm and MIC = 0.32 mM/ | IZ = 24 mm/ | ||||
| IZ = 23 mm and MIC = 0.37 mM/ | IZ = 22 mm/ | ||||
| IZ = 23 mm and MIC = 0.87 mM/ | IZ = 23 mm/ | ||||
| IZ = 24 mm and MIC = 1.14 mM/ | |||||
| 48 |
| IZ = 23 mm and MIC = 0.12 mM/ | Netilmicin | IZ = 25 mm and MIC = 0.009 mM/ |
|
| IZ = 24 mm and MIC = 0.12 mM/ | IZ = 23 mm and MIC = 0.011 mM/ | ||||
| IZ = 24 mm and MIC = 0.13 mM/ | IZ = 23 mm and MIC = 0.015 mM/ | ||||
| IZ = 23 mm and MIC = 0.15 mM/ | IZ = 22 mm and MIC = 0.01 mM/ | ||||
| IZ = 23 mm and MIC = 0.16 mM/ | IZ = 25 mm and MIC = 0.004 mM/ | ||||
| IZ = 24 mm and MIC = 0.18 mM/ | IZ = 21 mm and MIC = 0.005 mM/ | ||||
| IZ = 24 mm and MIC = 0.23 mM/ | IZ = 24 mm and MIC = 0.015 mM/ | ||||
| 49 |
| IZ = 24 mm and MIC = 0.14 mM/ | Netilmicin | IZ = 25 mm and MIC = 0.009 mM/ |
|
| IZ = 23 mm and MIC = 0.16 mM/ | IZ = 23 mm and MIC = 0.015 mM/ | ||||
| IZ = 24 mm and MIC = 0.17 mM/ | IZ = 21 mm and MIC = 0.005 mM/ | ||||
| IZ = 22 mm and MIC = 0.18 mM/ | IZ = 22 mm and MIC = 0.01 mM/ | ||||
| IZ = 24 mm and MIC = 0.19 mM/ | IZ = 25 mm and MIC = 0.004 mM/ | ||||
| IZ = 23 mm and MIC = 0.19 mM/ | IZ = 24 mm and MIC = 0.015 mM/ | ||||
| IZ = 24 mm and MIC = 0.26 mM/ | |||||
| 50 |
| IZ = 18 mm and MIC = 0.94 mM/ | Netilmicin | IZ = 23 mm and MIC = 0.015 mM/ |
|
| IZ = 17 mm and MIC = 1.10 mM/ | IZ = 22 mm and MIC = 0.01 mM/ | ||||
| IZ = 17 mm and MIC = 1.12 mM/ | IZ = 25 mm and MIC = 0.009 mM/ | ||||
| IZ = 18 mm and MIC = 1.20 mM/ | IZ = 23 mm and MIC = 0.011 mM/ | ||||
| IZ = 19 mm and MIC = 1.23 mM/ | IZ = 21 mm and MIC = 0.005 mM/ | ||||
| IZ = 18 mm and MIC = 1.32 mM/ | IZ = 25 mm and MIC = 0.004 mM/ | ||||
| IZ = 24 mm and MIC = 0.015 mM/ | |||||
| 51 |
| IZ = 17 mm and MIC = 0.92 mM/ | Netilmicin | IZ = 23 mm and MIC = 0.015 mM/ |
|
| IZ = 18 mm and MIC = 1.01 mM/ | IZ = 22 mm and MIC = 0.01 mM/ | ||||
| IZ = 19 mm and MIC = 1.02 mM/ | IZ = 23 mm and MIC = 0.011 mM/ | ||||
| IZ = 18 mm and MIC = 1.09 mM/ | IZ = 25 mm and MIC = 0.009 mM/ | ||||
| IZ = 19 mm and MIC = 1.15 mM/ | IZ = 25 mm and MIC = 0.004 mM/ | ||||
| IZ = 20 mm and MIC = 1.18 mM/ | IZ = 21 mm and MIC = 0.005 mM/ | ||||
| IZ = 17 mm and MIC = 1.24 mM/ | IZ = 24 mm and MIC = 0.015 mM/ | ||||
| 52 |
| IZ = 17 mm and MIC = 1.19 mM/ | Netilmicin | IZ = 25 mm and MIC = 0.009 mM/ |
|
| IZ = 18 mm and MIC = 1.21 mM/ | IZ = 24 mm and MIC = 0.015 mM/ | ||||
| IZ = 17 mm and MIC = 1.21 mM/ | IZ = 23 mm and MIC = 0.015 mM/ | ||||
| IZ = 17 mm and MIC = 1.31 mM/ | IZ = 22 mm and MIC = 0.01 mM/ | ||||
| IZ = 15 mm and MIC = 1.31 mM/ | IZ = 23 mm and MIC = 0.011 mM/ | ||||
| 53 |
| IZ = 16 mm and MIC = 0.99 mM/ | Netilmicin | IZ = 25 mm and MIC = 0.009 mM/ |
|
| IZ = 18 mm and MIC = 1.01 mM/ | IZ = 23 mm and MIC = 0.011 mM/ | ||||
| IZ = 17 mm and MIC = 1.24 mM/ | IZ = 23 mm and MIC = 0.015 mM/ | ||||
| IZ = 15 mm and MIC = 1.31 mM/ | IZ = 24 mm and MIC = 0.015 mM/ | ||||
| IZ = 17 mm and MIC = 1.32 mM/ | IZ = 22 mm and MIC = 0.01 mM/ | ||||
| 74 |
| IZ = 9.7 mm | Kanamycin sulfate | IZ = 24.7 mm |
|
| 76 |
| IZ = 13 mm/ | Kanamycin sulfate | IZ = 24.7 mm |
|
| IZ = 12 mm/ | |||||
| IZ = 9 mm/ | |||||
| IZ = 8 mm/ | |||||
| IZ = 7 mm/ | |||||
| 85 |
| IZ = 11.2 mm | Kanamycin sulfate | IZ = 24.7 mm |
|
| 86 |
| IZ = 9.1 mm | Kanamycin sulfate | IZ = 24.7 mm |
|
| 87 |
| IZ = 10.3 mm | Kanamycin sulfate | IZ = 24.7 mm |
|
| 206 |
| MIC = 15.5 μg mL−1/ | Ampicillin | MIC = 100 μg mL−1/ |
|
| MIC = 7.8 μg mL−1 | |||||
| EC50 = 21.9 μg mL−1/ | Mildothane | MIC = 12.5 μg mL−1/ | |||
| EC50 = 19.4 μg mL−1/ | MIC = 25.0 μg mL−1/ | ||||
| EC50 = 15.2 μg mL−1/ | EC50 = 17.0 μg mL−1/ | ||||
| EC50 = 43.8 μg mL−1/ | EC50 = 7.8 μg mL−1/ | ||||
| EC50 = 57.0 μg mL−1/ | |||||
| EC50 = 101.0 μg mL−1/ | |||||
| 267 and 297 |
| MIC = 32 μg mL−1/ |
| ||
|
| |||||
| 11 |
| IC50 = 25.4 μM/T cell inhibition |
| ||
| 170 |
| IC50 = 21.6 μM/T cell inhibition |
| ||
| 222 |
| IC50 = 27.8 μM/T cell inhibition |
| ||
| 409 |
| IC50 = 1.0 μM/T cell inhibition |
| ||
| To arrest the G2/M phase of the T cell cycle | |||||
| To decrease IL-6 and IL-17 levels in T cells | |||||
| 219, 225, 228, 279–280, 291, and 439 |
| The inhibitory effects on IL-1β and TNF-α, and PGE2 were comparable with positive control dexamethasone |
| ||
|
| |||||
| 90 |
| IC10 = 3.73 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| 126 |
| IC10 = 7.06 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| 257 |
| IC10 = 5.51 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| 448 |
| IC10 = 11.78 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| The MeOH extract of |
| IC10 = 2.17 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| The MeOH extract of |
| IC10 = 3.82 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| The MeOH extract of |
| IC10 = 3.01 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| The MeOH extract of |
| IC10 = 2.58 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| The MeOH extract of |
| IC10 = 1.61 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
| The MeOH extract of |
| IC10 = 4.32 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell | Ketotifen fumarate | IC10 = 1.37 μg mL−1/histamine and β-hexosaminidase inhibition in RBL-2H3 cell |
|
|
| |||||
| 29 |
| EC50 = 24.5 μM/glucose-evoked podocyte injury inhibition | Astragaloside IV | EC50 = 15.4 μM/glucose-evoked podocyte injury inhibition |
|
| 126 |
| EC50 = 3.0 μM/glucose-evoked podocyte injury inhibition | Astragaloside IV | EC50 = 15.4 μM/glucose-evoked podocyte injury inhibition |
|
| 224 |
| EC50 = 10.2 μM/glucose-evoked podocyte injury inhibition | Astragaloside IV | EC50 = 15.4 μM/glucose-evoked podocyte injury inhibition |
|
| 264 |
| EC50 = 12.0 μM/glucose-evoked podocyte injury inhibition | Astragaloside IV | EC50 = 15.4 μM/glucose-evoked podocyte injury inhibition |
|
| 405 |
| EC50 = 3.80 μM/glucose-evoked podocyte injury inhibition | Astragaloside IV | EC50 = 15.4 μM/glucose-evoked podocyte injury inhibition |
|
| 379 and 384–386 |
| IC50 > 50 μM/α-glucosidase inhibition |
| ||
|
| |||||
| 39 |
| MIR = 12.5 μg/AChE inhibition | Galanthamine | MIR = 0.004 μg/AChE inhibition |
|
| 220 |
| IC50 = 12.5 μg/AChE inhibition |
| ||
| 221 |
| IC50 = 12.5 μg/AChE inhibition |
| ||
|
| |||||
| 165 |
| IC50 = 12.5 mg mL−1/anti-manic activity in |
| ||
|
| |||||
| 126 |
| 88% Cough inhibition/citric acid activated Guinea pig cough model |
| ||
| Interaction to δ-opioid receptor | |||||
| 250 |
| 76% Cough inhibition/citric acid activated Guinea pig cough model |
| ||
|
| |||||
| The alkaloidal extract of |
| To decrease in the number of contortion and stretching |
| ||
|
| |||||
| 112 |
| To decrease arterial blood pressure and heart rate |
| ||
| 208 |
| 13% Relaxation occurred rat aorta ring |
| ||
| 210 |
| 24% Relaxation occurred rat aorta ring |
| ||
| 211 |
| 26% Relaxation occurred rat aorta ring |
| ||
| 216 |
| 28% Relaxation occurred rat aorta ring |
| ||
| 219 |
| 40% Relaxation occurred rat aorta ring |
| ||
| 225 |
| 41% Relaxation occurred rat aorta ring |
| ||
| 227 |
| 15% Relaxation occurred rat aorta ring |
| ||
| 228 |
| 37% Relaxation occurred rat aorta ring |
| ||
| 229 |
| 19% Relaxation occurred rat aorta ring |
| ||
| 230 |
| 19% Relaxation occurred rat aorta ring |
| ||
| 239 |
| 23% Relaxation occurred rat aorta ring |
| ||